Patents by Inventor Christopher Mark Riviello

Christopher Mark Riviello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azinone and diazinone V3 inhibitors for depression and stress disorders
    Patent number: 8350043
    Abstract: Substituted pyridines, pyrimidines, pyrazines, pyridinones, pyrimidinones, pyrazinones and phenylacetamides useful in treating depression, stress and other disorders are disclosed. The compounds are of the formualae: Other embodiments are also disclosed.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: January 8, 2013
    Assignee: Pharmacopeia, Inc.
    Inventors: Jeffrey John Letourneau, Koc-Kan Ho, Michael J. Ohlmeyer, Patrick Jokiel, Christopher Mark Riviello
  • Nitrogen heterocycle biaryls for osteoporosis and other diseases
    Patent number: 7365209
    Abstract: Nitrogen heterocycle biaryls having a carboxylate terminus are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity. Compounds of formula: are disclosed.
    Type: Grant
    Filed: February 10, 2004
    Date of Patent: April 29, 2008
    Assignee: Pharmacopeia, Inc.
    Inventors: Jeffrey John Letourneau, Vidyahar Paradkar, Michael H. J. Ohlmeyer, Lawrence W. Dillard, John J. Baldwin, Christopher Mark Riviello, Angela Wong, Yaing Rong
  • Pyrimidine and triazine kinase inhibitors
    Patent number: 6943161
    Abstract: Compounds that selectively inhibit inappropriate kinase activities and methods for their preparation are disclosed. In one embodiment, the compounds are represented by Formula I, As selective inhibitors of inappropriate kinase activities, the compounds of the present invention are useful in the treatment of conditions associated with such activity, including, but not limited to, inflammatory and autoimmune responses, diabetes, asthma, psoriasis, inflammatory bowel disease, transplantation rejection, and tumor metastasis. Also disclosed are methods of inhibiting inappropriate kinase activities and methods of treating conditions associated with such activities.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: September 13, 2005
    Assignee: Pharmacopela Drug Discovery, Inc.
    Inventors: Shawn David Erickson, James Inglese, Jeffrey John Letourneau, Christopher Mark Riviello
  • Pyrimidine and triazine kinase inhibitors
    Publication number: 20030149041
    Abstract: Compounds that selectively inhibit inappropriate kinase activities and methods for their preparation are disclosed.
    Type: Application
    Filed: June 28, 2002
    Publication date: August 7, 2003
    Applicant: Pharmacopeia, Inc.
    Inventors: Shawn David Erickson, James Inglese, Jeffrey John Letourneau, Christopher Mark Riviello
  • Class of thiomorpholino substituted thiazoles
    Patent number: 6380187
    Abstract: Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: April 30, 2002
    Inventors: Dingwei Tim Yu, Orest Taras Macina, Ila Sircar, Jagadish Chandra Sircar, Christopher Mark Riviello
  • Thiadiazole antifungal agents
    Publication number: 20020002193
    Abstract: Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.
    Type: Application
    Filed: December 5, 2000
    Publication date: January 3, 2002
    Inventors: Dingwei Tim Yu, Orest Taras Macina, Ila Sircar, Jagadish Chandra Sircar, Christopher Mark Riviello
  • Class of piperazino substituted thiazoles
    Patent number: 6281217
    Abstract: Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: August 28, 2001
    Inventors: Dingwei Tim Yu, Orest Taras Macina, Ila Sircar, Jagadish Chandra Sircar, Christopher Mark Riviello
  • Oxadiazole antifungal agents
    Patent number: 6277873
    Abstract: Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: August 21, 2001
    Inventors: Dingwei Tim Yu, Orest Taras Macina, Ila Sircar, Jagadish Chandra Sircar, Christopher Mark Riviello
  • Novel class of piperazino substituted thiazoles
    Publication number: 20010000512
    Abstract: Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.
    Type: Application
    Filed: December 5, 2000
    Publication date: April 26, 2001
    Inventors: Dingwei Tim Yu, Orest Taras Macina, Ila Sircar, Jagadish Chandra Sircar, Christopher Mark Riviello
  • PYRIDYL SUBSTITUTED THIAZOLES
    Publication number: 20010000178
    Abstract: Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.
    Type: Application
    Filed: December 5, 2000
    Publication date: April 5, 2001
    Inventors: Dingwei Tim Yu, Orest Taras Macina, Ila Sircar, Jagadish Chandra Sircar, Christopher Mark Riviello
  • Novel class of thiomorpholino substituted thiazoles
    Publication number: 20010000177
    Abstract: Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.
    Type: Application
    Filed: December 5, 2000
    Publication date: April 5, 2001
    Inventors: Dingwei Tim Yu, Orest Taras Macina, Ila Sircar, Jagadish Chandra Sircar, Christopher Mark Riviello
  • Diaryl substituted thiazoles useful in the treatment of fungal infections
    Patent number: 6156776
    Abstract: Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: December 5, 2000
    Inventors: Dingwei Tim Yu, Orest Taras Macina, Ila Sircar, Jagadish Chandra Sircar, Christopher Mark Riviello